Tema Heart & Health ETF HRTS
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.75%
- Net assets
- $51.9M
- Holdings
- 45
- 12-month distribution yield
- 1.25%
- Asset class
- Equity
Tema Heart & Health ETF (HRTS) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Tema. Its category is Equity · Global (equity). Its last price was US$37.75 on 20 Oct 2026. Its net expense ratio is 0.75% a year, from its prospectus dated 29 Jun 2026. It reported net assets of US$51.92 million as of 31 May 2026. Its latest holdings report lists 45 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.47 a unit, a 12-month distribution yield of 1.25%, paid yearly.
Fees
- Total annual operating expenses (gross)
- 0.99%
- Net, after fee waivers or reimbursements
- 0.75%
- Management fee
- 0.99%
- Prospectus date
- 29 Jun 2026
- Filed with the SEC
- 29 Jun 2026
Size and reporting
- Net assets
- $51,915,425
- Total assets
- $51,947,871
- Holdings as of
- 31 May 2026
- Report made public
- 29 Jul 2026 (59 days after the month end)
Top holdings
Largest 25 of 45 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 11.52% | $6.0M | Equity (common) | United States | USD |
| 2 | UnitedHealth Group Inc | US91324P1021 | 5.24% | $2.7M | Equity (common) | United States | USD |
| 3 | Novo Nordisk A/S | DK0062498333 | 5.24% | $2.7M | Equity (common) | Denmark | DKK |
| 4 | Roche Holding AG | US7711951043 | 4.50% | $2.3M | Equity (common) | Switzerland | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 4.27% | $2.2M | Equity (common) | United States | USD |
| 6 | AstraZeneca PLC | GB0009895292 | 4.00% | $2.1M | Equity (common) | United Kingdom | GBP |
| 7 | Thermo Fisher Scientific Inc | US8835561023 | 3.97% | $2.1M | Equity (common) | United States | USD |
| 8 | Johnson & Johnson | US4781601046 | 3.59% | $1.9M | Equity (common) | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 3.43% | $1.8M | Equity (common) | United States | USD |
| 10 | Novartis AG | CH0012005267 | 3.38% | $1.8M | Equity (common) | Switzerland | CHF |
| 11 | Revolution Medicines Inc | US76155X1000 | 3.33% | $1.7M | Equity (common) | United States | USD |
| 12 | Vertex Pharmaceuticals Inc | US92532F1003 | 2.93% | $1.5M | Equity (common) | United States | USD |
| 13 | Danaher Corp | US2358511028 | 2.66% | $1.4M | Equity (common) | United States | USD |
| 14 | Abbott Laboratories | US0028241000 | 2.61% | $1.4M | Equity (common) | United States | USD |
| 15 | Bridgebio Pharma Inc | US10806X1028 | 2.59% | $1.3M | Equity (common) | United States | USD |
| 16 | Cytokinetics Inc | US23282W6057 | 2.52% | $1.3M | Equity (common) | United States | USD |
| 17 | AbbVie Inc | US00287Y1091 | 2.40% | $1.2M | Equity (common) | United States | USD |
| 18 | Bristol-Myers Squibb Co | US1101221083 | 2.09% | $1.1M | Equity (common) | United States | USD |
| 19 | Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd | US8816242098 | 2.06% | $1.1M | Equity (common) | Israel | USD |
| 20 | Dexcom Inc | US2521311074 | 1.92% | $996K | Equity (common) | United States | USD |
| 21 | Amgen Inc | US0311621009 | 1.91% | $992K | Equity (common) | United States | USD |
| 22 | Medtronic PLC | IE00BTN1Y115 | 1.88% | $975K | Equity (common) | Ireland | USD |
| 23 | Edwards Lifesciences Corp | US28176E1082 | 1.75% | $907K | Equity (common) | United States | USD |
| 24 | McKesson Corp | US58155Q1031 | 1.71% | $888K | Equity (common) | United States | USD |
| 25 | Regeneron Pharmaceuticals Inc | US75886F1075 | 1.67% | $866K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.16% | |
| Short-term investment vehicles (cash funds) | 0.72% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 74.86% | |
| Switzerland | 7.88% | |
| Denmark | 6.99% | |
| United Kingdom | 4.00% | |
| Israel | 2.06% | |
| Ireland | 1.88% | |
| Japan | 1.33% | |
| Canada | 0.88% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 84.94% | |
| Danish krone (DKK) | 6.23% | |
| British pound (GBP) | 4.00% | |
| Swiss franc (CHF) | 3.38% | |
| Japanese yen (JPY) | 1.33% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 68.61% | |
| Industrials | 6.63% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.4730
- 12-month yield
- 1.25%
- Frequency
- Yearly
- Latest ex-date
- 10 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.4730) ÷ latest price ($37.75) × 100 = 1.25%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (2 payments)
| Ex-date | Amount per unit |
|---|---|
| 10 Dec 2025 | $0.4730 |
| 11 Dec 2024 | $0.4690 |
Filings and sources
- Form N-PORT report for May 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000081541) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- HRTS and VT Vanguard Total World Stock Index ETF
- HRTS and SMH VanEck Semiconductor ETF
- HRTS and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- HRTS and CGDV Capital Group Dividend Value ETF